https://orcid.org/0000-0003-3085-7964
References
- Willén L, Berglund A, Bergström S, et al. Are older patients with non-small cell lung cancer receiving optimal care? A population-based study. Acta Oncol. 2021:1–9. DOI:https://doi.org/10.1080/0284186X.2021.2000637
- Kocak MZ. Comment on “Frailty screening by geriatric-8 and 4-meter gait speed test is feasible and predicts postoperative complications in elderly colorectal cancer patients”. J Geriatr Oncol. 2021;12(4):685.
- Kocak MZ. Letter to the editor regarding the article ‘Frailty and skeletal muscle in older adults with cancer’. J Geriatr Oncol. 2020;11(6):1041.
- Kroenke CH, Neugebauer R, Meyerhardt J, et al. Analysis of body mass index and mortality in patients with colorectal cancer using causal diagrams. JAMA Oncol. 2016;2(9):1137–1145.
- Vatten LJ, Kvinnsland S. Prospective study of height, body mass index and risk of breast cancer. Acta Oncol. 1992;31(2):195–200.
- Meyerhardt JA, Niedzwiecki D, Hollis D, et al. Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from cancer and leukemia group B 89803. J Clin Oncol. 2008;26(25):4109–4115.
- Curcio F, Sasso G, Liguori I, et al. The reverse metabolic syndrome in the elderly: is it a “catabolic” syndrome? Aging Clin Exp Res. 2018;30(6):547–554.
- Shachar SS, Williams GR, Muss HB, et al. Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review. Eur J Cancer. 2016;57:58–67.
- Williams GR, Rier HN, McDonald A, et al. Sarcopenia & aging in cancer. J Geriatr Oncol. 2019;10(3):374–377.
- Cortellini A, Ricciuti B, Tiseo M, et al. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥50%: a multicenter study with external validation. J Immunother Cancer. 2020;8(2):e001403.